Last reviewed · How we verify
intravenous hydromorphone
At a glance
| Generic name | intravenous hydromorphone |
|---|---|
| Also known as | HI |
| Sponsor | Jun Wang |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain (PHASE4)
- Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia (PHASE4)
- The Impact of Intraoperative Methadone on Postoperative Opioid Use (PHASE3)
- Reducing Pain With Methadone and Ketamine in Liver Transplant (PHASE4)
- Intravenous Hydromorphone for the Treatment of Acute Pain (PHASE1, PHASE2)
- Fentanyl Versus Hydromorphone in Patients on Mechanical Ventilation (PHASE2)
- Methadone as an Alternative Treatment for Children Underdoing HSCT (PHASE3)
- IV vs Epidural Opioids + Epidural Local Anesthetic for Laparotomy Analgesia (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |